Treosulfan

ATC Code L01AB02

Treosulfan

Definition

The prodrug of a bifunctional sulfonate alkylating agent with myeloablative, immunosuppressive, and antineoplastic activities. Under physiological conditions, treosulfan converts nonenzymatically to L-diepoxybutane via a monoepoxide intermediate. The monoepoxide intermediate and L-diepoxybutane alkylate DNA at guanine residues and produce DNA interstrand crosslinks, resulting in DNA fragmentation and apoptosis. In escalated doses, this agent also exhibits myeloablative and immunosuppressive activities.

Also known as (S-(R*,R*))-1,2,3,4-butanetetrol,1,4-dimethanesulfonate, 1,2,3, 4-Butanetetrol, 1,4-dimethanesulfonate, [R-(R*,S*)]-, Dihydroxybusulfan, Grafapex, L-Threitol 1,4-dimethanesulfonate, Ovastat, Trecondi, TREOSULFAN, Treosulphan, Tresulfon — per NCIT

Also identified as